C. G. Gunawardana

发表

Comprehensive analysis of conditioned media from ovarian cancer cell lines identifies novel candidate markers of epithelial ovarian cancer.

E. Diamandis, C. Kuk, A. Soosaipillai, 2009, Journal of proteome research.

Cadmium inhibits both intrinsic and extrinsic apoptotic pathways in renal mesangial cells.

D. Templeton, C. G. Gunawardana, R. Martinez, 2006, American journal of physiology. Renal physiology.

Identifying novel autoantibody signatures in ovarian cancer using high-density protein microarrays.

E. Diamandis, C. G. Gunawardana, N. Memari, 2009, Clinical biochemistry.

CRISPR-Cas9-Based Knockout of the Prion Protein and Its Effect on the Proteome

G. Schmitt-Ulms, Hansen Wang, Sarah E. Macisaac, 2014, PloS one.

Nidogen-2: a new serum biomarker for ovarian cancer.

E. Diamandis, Yingye Zheng, C. Kuk, 2010, Clinical biochemistry.

The Human Tau Interactome: Binding to the Ribonucleoproteome, and Impaired Binding of the Proline-to-Leucine Mutant at Position 301 (P301L) to Chaperones and the Proteasome*

G. Schmitt-Ulms, Hansen Wang, I. Mueller, 2015, Molecular & Cellular Proteomics.

High throughput proteomic strategies for identifying tumour-associated antigens.

E. Diamandis, C. G. Gunawardana, 2007, Cancer letters.

Discovery of novel ovarian cancer biomarkers via proteomics and mass spectrometry.

C. G. Gunawardana, 2010 .

Mining the Ovarian Cancer Ascites Proteome for Potential Ovarian Cancer Biomarkers*S

E. Diamandis, V. Kulasingam, C. Kuk, 2009, Molecular & Cellular Proteomics.

Overcoming barriers and thresholds – signaling of oligomeric Aβ through the prion protein to Fyn

G. Schmitt-Ulms, Hansen Wang, C. G. Gunawardana, 2013, Molecular Neurodegeneration.

Comprehensive analysis of conditioned media from ovarian cancer cell lines identifies novel candidate markers of epithelial ovarian cancer.

E. Diamandis, C. Kuk, A. Soosaipillai, 2009, Journal of proteome research.